Lymph node involvement in ampullary cancer: The importance of the number, ratio, and location of metastatic nodes

Journal of Surgical Oncology

Volumn 100, Issue 1, 2009, Pages 19-24

  Sierzega, Marek ^a   Nowak, Krystyna ^a   Kulig, Jan ^a   Matyja, Andrzej ^a   Nowak, Wojciech ^a   Popiela, Tadeusz ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Ampullary cancer; Lymphatic metastasis; Prognosis; Prognostic factors

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSISTANT; PANCREAS RESECTION; PANCREATICODUODENECTOMY; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME; VATER PAPILLA CARCINOMA; BILE DUCT TUMOR; MIDDLE AGED; MORTALITY; PATHOLOGY; VATER PAPILLA;

ADULT; AGED; AGED, 80 AND OVER; AMPULLA OF VATER; COMMON BILE DUCT NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS;

EID: 67649394399     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21283     Document Type: Article

References (35)

1. Michelassi F, Erroi F, Dawson PJ, et al.: Experience with 647 consecutive tumors of the duodenum, ampulla, head of the pancreas, and distal common bile duct. Ann Surg 1989;210:544-554. (Pubitemid 19242618)
2. Allema JH, Reinders ME, van Gulik TM, et al.: Prognostic factors for survival after pancreaticoduodenectomy for patients with carcinoma of the pancreatic head region. Cancer 1995;75:2069-2076.
3. Fisher WE, Bakey ME: Differences between ampullary, periampullary and pancreatic cancer.World J Surg 2007;31:144-146.
4. Nakase A, Matsumoto Y, Uchida K, et al.: Surgical treatment of cancer of the pancreas and the periampullary region: Cumulative results in 57 institutions in Japan. Ann Surg 1977;185:52-57. (Pubitemid 8015190)
5. Qiao QL, Zhao YG, Ye ML, et al.: Carcinoma of the ampulla of Vater: Factors influencing long-term survival of 127 patients with resection. World J Surg 2007;31:137-143. (Pubitemid 46089556)
6. Yamaguchi K, Enjoji M: Carcinoma of the ampulla of vater. A clinicopathologic study and pathologic staging of 109 cases of carcinoma and 5 cases of adenoma. Cancer 1987;59:506-515.
7. Howe JR, Klimstra DS, Moccia RD, et al.: Factors predictive of survival in ampullary carcinoma. Ann Surg 1998;228:87-94. (Pubitemid 30190320)
8. Talamini MA, Moesinger RC, Pitt HA, et al.: Adenocarcinoma of the ampulla of Vater. A 28-year experience. Ann Surg 1997;225:590-599.
9. Beger HG, Treitschke F, Gansauge F, et al.: Tumor of the ampulla of Vater: Experience with local or radical resection in 171 consecutively treated patients. Arch Surg 1999;134:526-532. (Pubitemid 29218124)
10. de Castro SM, van Heek NT, Kuhlmann KF, et al.: Surgical management of neoplasms of the ampulla of Vater: Local resection or pancreatoduodenectomy and prognostic factors for survival. Surgery 2004;136:994-1002. (Pubitemid 39452298)
11. Balachandran P, Sikora SS, Kapoor S, et al.: Long-term survival and recurrence patterns in ampullary cancer. Pancreas 2006;32:390-395. (Pubitemid 43772195)
12. Hsu HP, Yang TM, Hsieh YH, et al.: Predictors for patterns of failure after pancreaticoduodenectomy in ampullary cancer. Ann Surg Oncol 2007;14:50-60. (Pubitemid 44954270)
13. Takashima M, Ueki T, Nagai E, et al.: Carcinoma of the ampulla of Vater associated with or without adenoma: A clinicopathologic analysis of 198 cases with reference to p53 and Ki-67 immunohistochemical expressions. Mod Pathol 2000;13:1300-1307. (Pubitemid 32014667)
14. Terasawa H, Uchiyama K, Tani M, et al.: Impact of lymph node metastasis on survival in patients with pathological T1 carcinoma of the ampulla of Vater. J Gastrointest Surg 2006;10:823-828. (Pubitemid 43870161)
15. Yoon YS, Kim SW, Park SJ, et al.: Clinicopathologic analysis of early ampullary cancers with a focus on the feasibility of ampullectomy. Ann Surg 2005;242:92-100. (Pubitemid 40917972)
16. Allema JH, Reinders ME, van Gulik TM, et al.: Results of pancreaticoduodenectomy for ampullary carcinoma and analysis of prognostic factors for survival. Surgery 1995;117:247-253.
17. Sierzega M, Popiela T, Kulig J, et al.: The ratio of metastatic/resected lymph nodes is an independent prognostic factor in patients with node-positive pancreatic head cancer. Pancreas 2006;33:240-245. (Pubitemid 44470138)
18. Pawlik TM, Gleisner AL, Cameron JL, et al.: Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer. Surgery 2007;141:610-618. (Pubitemid 46616937)
19. Schwarz RE, Smith DD: Extent of lymph node retrieval and pancreatic cancer survival: Information from a large US population database. Ann Surg Oncol 2006;13:1189-1200. (Pubitemid 44440420)
20. Roder JD, Schneider PM, Stein HJ, et al.: Number of lymph node metastases is significantly associated with survival in patients with radically resected carcinoma of the ampulla of Vater. Br J Surg 1995;82:1693-1696.
21. Shirai Y, Tsukada K, Ohtani T, et al.: Carcinoma of the ampulla of Vater: Is radical lymphadenectomy beneficial to patients with nodal disease? J Surg Oncol 1996;61:190-194.
22. Schwarz RE, Smith DD: Lymph node dissection impact on staging and survival of extrahepatic cholangiocarcinomas, based on U.S. population data. J Gastrointest Surg 2007;11:158-165.
23. Sakata J, Shirai Y, Wakai T, et al.: Number of positive lymph nodes independently affects long-term survival after resection in patients with ampullary carcinoma. Eur J Surg Oncol 2007;33:346-351. (Pubitemid 46488664)
24. Ampulla of Vater. In: Greene FL, Compton CC, Fritz AG, Shah J, editors. AJCC cancer staging atlas. New York: Springer; 2006. pp. 147-154.
25. Japanese Society of Biliary Surgery. Classification of biliary tract carcinoma. Tokyo: Kanehara; 2004.
26. Slinker BK, Glantz SA: Multiple regression for physiological data analysis: The problem of multicollinearity. Am J Physiol 1985;249:R1-R12. (Pubitemid 15243826)
27. Liu RX, Kuang J, Gong Q, et al.: Principal component regression analysis with SPSS. Comput Methods Programs Biomed 2003;71:141-147. (Pubitemid 36577649)
28. Kayahara M, Nagakawa T, Ohta T, et al.: Surgical strategy for carcinoma of the papilla of Vater on the basis of lymphatic spread and mode of recurrence. Surgery 1997;121:611-617. (Pubitemid 27251899)
29. Bhatia S, Miller RC, Haddock MG, et al.: Adjuvant therapy for ampullary carcinomas: The Mayo Clinic experience. Int J Radiat Oncol Biol Phys 2006;66:514-519. (Pubitemid 44332725)
30. Beger HG, Thorab FC, Liu Z, et al.: Pathogenesis and treatment of neoplastic diseases of the papilla of Vater: Kausch-Whipple procedure with lymph node dissection in cancer of the papilla of Vater. J Hepatobiliary Pancreat Surg 2004;11:232-238. (Pubitemid 39264124)
31. Sakata E, Shirai Y, Yokoyama N, et al.: Clinical significance of lymph node micrometastasis in ampullary carcinoma. World J Surg 2006;30:985-991. (Pubitemid 43824408)
32. Mizuno T, Ishizaki Y, Ogura K, et al.: Clinical significance of immunohistochemically detectable lymph node metastasis in adenocarcinoma of the ampulla of Vater. Br J Surg 2006;93:221-225. (Pubitemid 43259609)
33. O'Connell JB, Maggard MA, Manunga J, Jr., et al.: Survival after resection of ampullary carcinoma: A national population-based study. Ann Surg Oncol 2008;15:1820-1827.
34. Brown KM, Tompkins AJ, Yong S, et al.: Pancreaticoduodenectomy is curative in the majority of patients with node-negative ampullary cancer. Arch Surg 2005;140:529-532. (Pubitemid 40965055)
35. Shirai Y, Ohtani T, Tsukada K, et al.: Patterns of lymphatic spread of carcinoma of the ampulla of Vater. Br J Surg 1997;84:1012-1016. (Pubitemid 27310882)